Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters

Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters

Assessment of treatment response to targeted therapies such as everolimus is difficult, especially in slow-growing tumors such as NETs. In this retrospective study, 17 patients with pancreatic neuroendocrine tumors (pNETs) and hepatic metastases (NELMs) (42 target lesions) who received everolimus we...

Full description

Bibliographic Details
Main Authors: Maria Ingenerf, Sophia Kiesl, Michael Winkelmann, Christoph J. Auernhammer, Johannes Rübenthaler, Freba Grawe, Matthias P. Fabritius, Jens Ricke, Christine Schmid-Tannwald
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Biomedicines
Subjects:
therapy response
neuroendocrine tumors
DWI
everolimus
Online Access:https://www.mdpi.com/2227-9059/10/10/2618

Similar Items

Similar Items